$EIDX Eidos Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Eidos Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eidos Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Eidos Therapeutics, Inc. for free.
CIK Number: 0001731831
IRS Number: 463733671
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: EIDX
Company Address: 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO 94104
Phone number: 415-887-1471
Eidos Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Option Exercise | D | 13.20 | 70,000 | 924,000 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | U | 0.00 | 380,467 | 0 | 0 | 380.5 K to 0 (-100.00 %) |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Gift | G | 0.00 | 500 | 0 | 380,467 | 381 K to 380.5 K (-0.13 %) |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Rohlen Douglas | Director | Option Exercise | D | 0.00 | 4,526 | 0 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Rohlen Douglas | Director | Option Exercise | D | 41.42 | 21,447 | 888,335 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Valle Franco | Senior Vice Preside ... | Option Exercise | D | 7.24 | 24,350 | 176,294 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | D | 13.20 | 53,157 | 701,672 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | D | 17.00 | 9,469 | 160,973 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | U | 0.00 | 50,699 | 0 | 0 | 50.7 K to 0 (-100.00 %) |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | D | 20.34 | 43,056 | 875,759 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | D | 30.87 | 21,528 | 664,569 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | D | 48.51 | 21,528 | 1,044,323 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Lis William | Director | Option Exercise | D | 13.67 | 43,056 | 588,576 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Lis William | Director | Option Exercise | D | 30.87 | 21,528 | 664,569 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Lis William | Director | Option Exercise | D | 48.51 | 21,528 | 1,044,323 | 0 |